Početna › Ewingov sarkom › Michigan
Kliničke studije za Ewingov sarkom u državi Michigan
8 studija za Ewingov sarkom traži sudionike na lokacijama u državi Michigan.
Gradovi u državi Michigan
Službeni tekst studije (engleski)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Helen DeVos Children's Hospital, Grand Rapids
U tijeku regrutacijaFaza 1
Od 1 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Corewell Health ( Site 1001), Grand Rapids
U tijeku regrutacijaFaza 1/2
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- University of Michigan, Ann Arbor
- START Midwest Michigan, PC, Grand Rapids
U tijeku regrutacijaFaza 1
Od 12 do 85 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT03715933Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Hospital of Michigan/Wayne State University, Detroit
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262Lurbinectedin in FET-Fused Tumors
- University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 1/2
Od 10 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- William Beaumont University Hospital, Royal Oak
U tijeku regrutacija
Od 13 godina i više · Oba spola · Ažurirano 6. velj 2026. · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Corewell Health, Grand Rapids
U tijeku regrutacijaFaza 1/2
Od 2 do 30 godina · Oba spola · Ažurirano 3. velj 2026. · NCT05734066Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.